SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

FuelCell Energy, Inc. is an American clean energy technology company that delivers continuous, scalable baseload power for mission-critical applications globally. It engages in the development, design, production, construction, operation, and servicing of high-temperature fuel cells for clean electric power generation. The company’s fuel cell systems generate electricity directly at the point of use, enabling reliable, low-emission power for data centers, industrial facilities, utilities, and distributed generation customers. FuelCell Energy delivers commercially proven, modular, utility-scale systems backed by global fuel cell deployments approaching one gigawatt. The company was founded by Bernard Baker and Martin G. Klein in 1969 and is headquartered in Danbury, CT.

Fuelcell Energy Inc

FCEL is drawing attention amid a steep selloff, with traders debating elevated short interest and managements ability to scale production and turn data-center opportunities into firm business. Bulls point to AI power demand and potential contract growth, while bears focus on execution concerns, dilution and the companys long history of shareholder losses.

Coherent Corp. engages in the development, refinement, manufacturing, and marketing of engineered materials, opto-electronic components and devices, and lasers for use in the industrial, communications, electronics, and instrumentation markets. It operates through the following segments: Networking, Materials, and Lasers. The Networking segment leverages compound semiconductor technology platforms and deep knowledge of end-user applications. The Materials segment markets engineered materials and optoelectronic devices. The Lasers segment serves industrial customers in semiconductor capital equipment, display capital equipment, precision manufacturing, and aerospace and defense, as well as instrumentation customers in life sciences and scientific research. The company was founded by Carl J. Johnson in 1971 and is headquartered in Saxonburg, PA.

Coherent Corp

A sharp, volatile pullback across AI-optics stocks has put Coherents exposure to data-center spending in focus, with traders citing concerns about AI funding, capex sustainability, and stretched valuations rather than a clear company-specific setback. Some see the selloff as an overdone, sector-wide reset and point to continuing demand for optical connectivity, while others expect further weakness.

Zoom Communications, Inc. engages in the provision of a communications and collaboration platform. It operates through the following geographical segments: Americas, Asia Pacific, and Europe, Middle East, and Africa. The company was founded by Eric S. Yuan in 2011 and is headquartered in San Jose, CA.

Zoom Communications Inc. - Ordinary Shares - Class A

Zoom is drawing attention as traders focus on its Anthropic investment and the prospect of an Anthropic IPO, viewing ZM as a public-market proxy for the AI company. Some see the stake as underappreciated upside, while skeptics question its value and point to Zooms modest core-business growth and software competition.

Teladoc Health, Inc. engages in the provision of telehealthcare services using a technology platform via mobile devices, the Internet, video and phone. It operates through the following segments: Teladoc Health Integrated Care, BetterHelp, and Others. The Teladoc Health Integrated Care segment offers virtual medical services. The BetterHelp segment includes virtual mental health and other wellness services. The company was founded in June 2002 by George Byron Brooks, Michael Gorton, and Gary Wald and is headquartered in New York, NY.

Teladoc Health Inc

Discussion is centered on Teladocs upcoming quarterly report and whether it can show progress after lowering its outlook amid BetterHelps shift from cash-pay to insurance. Many traders doubt management can restore growth and profitability, while bulls point to insurance demand, Walmart and AI opportunities, and high short interest as possible catalysts; squeeze talk remains speculative.

Visa, Inc. engages in the provision of digital payment services. It also facilitates global commerce through the transfer of value and information among a global network of consumers, merchants, financial institutions, businesses, strategic partners, and government entities. It offers debit cards, credit cards, prepaid products, commercial payment solutions, and global automated teller machines. The company was founded by Dee Hock in 1958 and is headquartered in San Francisco, CA.

Visa Inc - Ordinary Shares - Class A

Visa Inc

Visas scheduled fiscal-year report is the main focus, with traders watching next-year margin guidance more closely than the expected earnings beat. Some see the stocks breakout and strength near record highs as bullish, while others flag overbought conditions and the risk of a pullback if guidance disappoints.

Phathom Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of novel treatments for gastrointestinal diseases. The company was founded by Tadataka Yamada, David Socks, Azmi Nabulsi, Aditya Kohli, and Roger Ulrich on January 9, 2018 and is headquartered in Florham Park, NJ.

Phathom Pharmaceuticals Inc

BDR Pharmaceuticals lawsuit challenging the FDAs refusal to accept a generic application for VOQUEZNA has raised concern about the drugs exclusivity and sent PHAT sharply lower. Traders debate whether the legal challenge poses a meaningful long-term threat or is an overreaction, noting that the case targets the FDA and does not concern a failure of the drug or its commercial launch.

Blackstone, Inc. engages in the provision of investment and fund management services. It operates through the following segments: Real Estate, Private Equity, Credit and Insurance, and Hedge Fund Solutions. The Real Estate segment includes management of opportunistic real estate funds, Core+ real estate funds, high-yield real estate debt funds, and liquid real estate debt funds. The Private Equity segment consists of management of flagship corporate private equity funds, sector and geographically focused corporate private equity funds, core private equity funds, an opportunistic investment platform, a secondary fund of funds business, infrastructure-focused funds, a life sciences investment platform, a growth equity investment platform, a multi-asset investment program for eligible high net worth investors and a capital markets services business. The Credit and Insurance segment refers to Blackstone Credit, which is organized into two overarching strategies: private credit which includes mezzanine direct lending funds, private placement strategies, stressed and distressed strategies and energy strategies, and liquid credit which consists of CLOs, closed-ended funds, open ended funds and separately managed accounts. In addition, the segment includes an insurer-focused platform, an asset-based finance platform, and publicly traded master limited partnership investment platform. The Hedge Fund Solutions segment focuses on Blackstone Alternative Asset Management, which manages a broad range of commingled and customized hedge fund of fund solutions. It also includes a GP Stakes business and investment platforms that invest directly, as well as investment platforms that seed new hedge fund businesses and create alternative solutions through daily liquidity products. The company was founded by Stephen Allen Schwarzman in 1985 and is headquartered in New York, NY.

Blackstone Inc

Blackstones Q3 results are driving attention: distributable earnings topped expectations, with strong inflows and record assets under management, while weaker realizations and year-over-year declines raised concerns about the quarters underlying quality. Traders are split between welcoming the fundraising strength and focusing on exit weakness and broader private-credit risks.

Cameco Corp. engages in the provision of uranium. It operates through the Uranium and Fuel Services segments. The Uranium segment is involved in the exploration for, mining, milling, purchase, and sale of uranium concentrate. The Fuel Services segment deals with the refining, conversion, and fabrication of uranium concentrate and the purchase and sale of conversion services. The company was founded in 1988 and is headquartered in Saskatoon, Canada.

Cameco Corp.

Camecos selloff to fresh lows is being tied by traders to Cigar Lake production disruptions and uncertainty around the Westinghouse IPO, with concern that operational issues could weigh on earnings. Bearish calls for further downside are countered by dip buyers and longer-term uranium bulls who see the weakness as an opportunity.

Icahn Enterprises LP is a holding company. It operates through the following segments: Investment, Automotive, Energy, Food Packaging, Real Estate, Home Fashion, Pharma, and Holding Company. The Investment segment consists of various private investment funds. The Automotive segment holds ownership in Icahn Automotive Group, LLC. The Energy segment refers to petroleum refining and marketing businesses. The Food Packaging segment involves the production and sale of cellulosic, fibrous, and plastic casings for the processed meat and poultry industry. The Real Estate segment offers rental real estate, property development, and resort activities. The Home Fashion segment deals with manufacturing, sourcing, marketing, distributing, and selling home fashion consumer products. The Pharma segments operate through Vivus, Inc., a specialized pharmaceutical company. The Holding Company segment manages acquisition and investment in operating businesses. The company was founded on February 17, 1987 and is headquartered in Sunny Isles Beach, FL.

Icahn Enterprises L P - Unit

Icahn Enterprises, L.P.

IEP is drawing attention amid a sharp selloff, with traders debating whether its next distribution is sustainable and whether portfolio changes can ease financial pressures. Some blame short selling and see squeeze potential, while others worry about a distribution cut, dilution, and managements track record.

Mastercard, Inc. is a technology company, which engages in the provision of payment solutions for the development and implementation of credit, debit, prepaid, commercial, and payment programs through its brands including Mastercard, Maestro, and Cirrus. It also offers cyber and intelligence solutions. The company was founded in November 1966 and is headquartered in Purchase, NY.

Mastercard Incorporated - Ordinary Shares - Class A

Mastercard Inc

Mastercard is drawing attention ahead of its quarterly report, with traders focused on forward guidance and payment trends more than the headline results. Sentiment is mixed: some point to the stocks recent strength, while others worry that weakness in American Express after its results could signal pressure across card networks.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Here's Why HCA Healthcare (HCA) is a Strong Value Stock

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Establishment Labs Holdings Inc. (ESTA) Expected to Beat Earnings Estimates: Should You Buy?

Establishment Labs (ESTA) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Countdown to HCA (HCA) Q3 Earnings: A Look at Estimates Beyond Revenue and EPS

Evaluate the expected performance of HCA (HCA) for the quarter ended September 2026, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for better insight.

HCA Healthcare to Host Eighth Annual Crush the Crisis National Prescription Drug Take Back Day

HCA Healthcare, Inc. (NYSE:HCA), one of the nations leading healthcare providers, today announced it will host its eighth annual Crush the Crisis national prescription drug take back day. On Saturday, Oct. 24, 2026, HCA Healthcare facilities from across the country will partner with local law...

Danaher (DHR) Tops Q3 Earnings and Revenue Estimates

Danaher (DHR) delivered earnings and revenue surprises of +9.90% and +0.10%, respectively, for the quarter ended September 2026. Do the numbers hold clues to what lies ahead for the stock?

Analysts Estimate HCA Healthcare (HCA) to Report a Decline in Earnings: What to Look Out for

HCA (HCA) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Here's Why HCA Healthcare (HCA) is a Strong Momentum Stock

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Why HCA Healthcare (HCA) is a Top Stock for the Long-Term

Finding strong, market-beating stocks with a positive earnings outlook becomes easier with the Focus List, a top feature of the Zacks Premium portfolio service.

Here's How Much a $1000 Investment in HCA Healthcare Made 10 Years Ago Would Be Worth Today

Why investing for the long run, especially if you buy certain popular stocks, could reap huge rewards.

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of HCA Healthcare, Inc. - HCA

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of HCA Healthcare, Inc. - HCA INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of HCA Healthcare, Inc. - HCAPR NewswireNEW YORK, Oct. 15, 2026NEW YORK, Oct. 15, 2026 /PRNewswire/ -- Pomerantz...

HCA Healthcare, Inc. is a health care services company, which engages in operating hospitals, freestanding surgery centers and emergency care facilities, urgent care facilities, walk-in clinics, diagnostic and imaging centers, radiation and oncology therapy centers, comprehensive rehabilitation and physical therapy centers, physician practices, home health, hospice, outpatient physical therapy home and community-based services providers, and various other facilities. The firm operates general and acute care hospitals that offer medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services, and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy. The company was founded by Dr. Thomas F. Frist, Jr in 1968 and is headquartered in Nashville, TN.

HCA Healthcare Inc

HCA Stock Plummets After Slashing 2026 Guidance – Marks Fifth Straight Day Of Losses

Equity

Neutral Sentiment

<ul class="summary-bullets"><li>HCA lowered its forecasts for net income, adjusted EBITDA, and earnings per share while making only a modest adjustment to its revenue outlook.</li><li>Cantor Fitzgerald said the weaker payer mix likely triggered the stock's sharp decline but maintained its 'Overweight' rating and $525 price target.</li><li>Other healthcare stocks, including Johnson &amp; Johnson, Eli Lilly, Merck, AbbVie, and UnitedHealth Group, also traded lower following HCA's update.</li></ul>HCA Healthcare (HCA) shares fell on Monday morning after the hospital operator cut its 2026 earnings outlook, blaming a worse-than-expected payer mix shift tied to losses in health insurance coverage.&nbsp;The company also raised the size of the headwind from health insurance exchanges, a sign that coverage changes are pressuring reimbursement more than it had previously modeled.<a href="https://stocktwits.com/symbol/HCA/">HCA stock</a> fell nearly 7% in morning trade to under $365, recovering from earlier lows seen in August last year and extending its losing streak. On Stocktwits, retail sentiment around the stock remained in ‘neutral’ territory with chatter at ‘normal’ levels.&nbsp;<figure class="image"><img src="https://news.stocktwits-cdn.com/HCA_2026_07_14_11_09_25_png_9c4cdbe62d.webp" alt="HCA_2026-07-14_11-09-25.png" width="1772" height="948"><figcaption>HCA stock performance since August 2026. | Source: TradingView</figcaption></figure>Some retailers on the platform expressed interest in buying the stock amid the downturn.<stembedurl>https://www.stocktwits.com/IAMCapital1/message/658966742</stembedurl><stembedurl>https://www.stocktwits.com/Only4TheShow/message/658985941</stembedurl><h2 class="st-heading-2">Guidance Cut, But Revenue Range Mostly Intact</h2>HCA lowered several key 2026 profit targets while leaving its revenue outlook only slightly narrower. The company now sees revenue of $77 billion to $79.5 billion, down from a prior range of $76.5 billion to $80 billion, while net income attributable to HCA is now expected to come in between $6.3 billion and $6.7 billion, versus an earlier range of $6.495 billion to $7.035 billion."Our colleagues continue to manage well through the positive and negative factors that have impacted our business in the first half of the year,” said Sam Hazen, Chief Executive Officer of HCA Healthcare. "As we look to the balance of the year, we have adjusted our guidance to reflect these factors."&nbsp;Adjusted earnings before interest, tax, depreciation, and amortization (EBITDA) guidance was also trimmed to $15.4 billion to $16.1 billion from $15.55 billion to $16.45 billion. Earnings per diluted share were cut to a range of $28.70 to $30.50, compared with the prior forecast of $29.10 to $31.50.&nbsp;<h2 class="st-heading-2">Health Insurance Exchange Headwinds Grow</h2>The company kept its 2026 capital spending plan unchanged at $5 billion to $5.5 billion, excluding acquisitions, suggesting it is not pulling back on longer-term investment even as profit expectations soften.HCA said the cuts were driven by the expectation of a larger unfavorable impact from health insurance exchanges. It stated that the drag on income before taxes would widen to between $1 billion and $1.2 billion from an earlier estimate of $600 million to $900 million. That points to a less favorable payer mix, meaning a larger share of patients are arriving with coverage that reimburses less richly than the company had anticipated.<h2 class="st-heading-2">Analysts Point To Payer Mix Concerns</h2>In a note to investors cited by TheFly, Cantor Fitzgerald said the guidance, due to worsening payor mix, is the likely trigger for the sharp stock sell-off. It added that the downturn is weighing on healthcare peers as results fell short of expectations. The firm has an ‘Overweight’ rating on HCA’s stock and a $525 price target.Shares of Johnson and Johnson (JNJ), expected to report earnings later this week, fell by nearly 2%. Shares of Eli Lilly (LLY) and Merck (MRK) dropped nearly 3% each, while AbbVie (ABBV) and UnitedHealth Group (UNH) moved over 1% lower.&nbsp;Earlier in the day, KeyBanc also lowered its price target on HCA Healthcare to $475 from $510 and kept an ‘Overweight’ rating on the shares, citing “uncertainty” around hospitals' core earnings trajectory.Read also:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/ibm-stock-tanks-to-2-month-lows-in-pre-market-ceo-says-company-faltered/cZZbDWbR7ps">IBM Stock Tanks To 2-Month Lows In Pre-Market – CEO Says Company ‘Faltered’ In Q2 As ‘Large Deals Failed To Close’ On Expected Timelines</a>For updates and corrections, email newsroom[at]stocktwits[dot]com

In this photo illustration, HCA Healthcare’s logo is on a smartphone with an economic stock exchange index graph in the background. (Photo Illustration by Budrul Chukrut/SOPA Images/LightRocket via Getty Images) 

HCA Healthcare (HCA) shares fell on Monday morning after the hospital operator cut its 2026 earnings outlook, blaming a worse-than-expected payer mix shift tied to losses in health insurance coverage. 

Why Is HCA Stock Falling Today?

The company attributed the guidance cut to a larger-than-expected shift in payer mix and a greater financial impact from health insurance exchanges.


Johnson & Johnson

Lilly(Eli) & Co

Merck & Co Inc

Unitedhealth Group Inc

Health Care Select Sector SPDR Fund

Track HCA stock price, charts, news and real-time market activity on Stocktwits. Join the HCA message board to follow investor discussions, retail trader sentiment, bullish and bearish signals around HCA Healthcare Inc stock.

HCA Stock Price Today - HCA Healthcare Inc News, Charts, Retail Sentiment

Up more than 1%

Flat to up 1%

Flat to down 1%

Down more than 1%

What do you think the S&amp;P 500&#39;s ($SPY) return will be next week?

Current Price	$469.03
Prev Close	$467.31
Open	$465.76
Dividend Yield	0.62%
50-Day Moving Average	$431.51
Beta	0.32
Avg. Volume	1.52M
PE Ratio	15.70

52-Week High	$556.52
52-Week Low	$353.99
Market Capitalization	$101.55B
EPS (Annual)	$28.33
Price to Book	-15.39
Revenue Per Employee	$236,250.00

Feed

News

Sentiment

Earnings

Fundamentals

Info

HCA Fundamentals